Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MEmbranous Nephropathy Trial Of Rituximab (MENTOR)

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Fernando Fervenza, Mayo Clinic Identifier:
First received: August 10, 2010
Last updated: November 23, 2015
Last verified: October 2015